跳至主要内容
临床试验/IRCT2014051017643N1
IRCT2014051017643N1已完成1 期

Investigation of the efficacy of a topical dosage form consisting lawsonia inermis extracts in reducing Fluoropyrimidines induced Hand-Foot Syndrome in cancerous patients

Pharmaceutical Sciences branch, Islamic Azad University(a part of razieh mohajerani's PharmD thesis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Taking 5-fluorouracil (5-fu) by injection or oraly Capecitabine as an anticancer drug; showing hand-foot syndrome; patient satisfaction; Having cancer. Exclusion criteria: Treatment change and discontinuing 5-fluorouracil (5-fu) and oral Capecitabine administration; Showing no hand-foot syndrome; Patient's death; Lack of cancer; Sensitivity to compounds of formula.

排除标准

  • 未提供

研究者

发起方
Pharmaceutical Sciences branch, Islamic Azad University(a part of razieh mohajerani's PharmD thesis

相似试验